
Gut Microbiota Identified as Critical Factor in Cancer Immunotherapy Success
Research reveals that gut microbial ecosystems significantly influence the effectiveness of PD-L1 and PD-1 checkpoint inhibitor therapies, with implications for overcoming treatment resistance and expanding applications to inflammatory and autoimmune diseases.
Read full story






















